PHILADELPHIA — (September 30, 2026) — The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious disease, is pleased to welcome Dana Nae Garcia to its Board of Trustees. Garcia is a seasoned healthcare and business executive with a strong background in building, transforming and improving businesses to create long-term value.
Currently, Garcia serves as Chief Operating and Transformation Officer at Konovo, a global healthcare insights and data platform, where she leads operations across North America, Europe, India, and Latin America. Prior to Konovo, Garcia held senior leadership positions at Aetion, a leading real-world evidence analytics platform serving biopharmaceutical companies, payers, and regulators, where she guided North American commercial operations and global client engagement efforts.
She has also held leadership roles at Vynamic, a healthcare consultancy and strategy firm, and Deloitte Consulting. She will serve on the Board’s Business Development and Communications & Marketing committees.
“Dana brings an exceptional combination of strategic vision, operational excellence, and deep healthcare industry expertise that will undoubtedly help Wistar advance our mission of accelerating biomedical discovery and translating science into improved human health,” said Dario Altieri, M.D., president and CEO of The Wistar Institute. “Her experience in the healthcare sector, coupled with her strong strategic acumen, makes her an ideal addition to our Board of Trustees. We look forward to the insights and perspective she will bring to the role.”
“I am honored to join Wistar’s Board of Trustees and contribute to an institution with such an extraordinary legacy of scientific excellence and discovery,” said Garcia. “As healthcare continues to evolve at a rapid pace, investments in foundational research are more important than ever. Wistar’s commitment to advancing groundbreaking science and translating discoveries into meaningful health impact makes this an exciting time to support the Institute’s mission.”
Garcia received a B.A. from Franklin and Marshall College and an MBA from the Wharton School of the University of Pennsylvania. She currently resides in the Greater Philadelphia region with her husband and two young children.
ABOUT THE WISTAR INSTITUTE:
The Wistar Institute is the nation’s first independent nonprofit institution devoted exclusively to foundational biomedical research and training. Since 1972, the Institute has held National Cancer Institute (NCI)-designated Cancer Center status. Through a culture and commitment to biomedical collaboration and innovation, Wistar science leads to breakthrough early-stage discoveries and life science sector start-ups. Wistar scientists are dedicated to solving some of the world’s most challenging problems in the field of cancer and immunology, advancing human health through early-stage discovery and training the next generation of biomedical researchers. wistar.org
